2型糖尿病病人胰岛素抵抗与血浆纤维蛋白原的相关性
[Abstract]:Background & objective: type 2 diabetes mellitus (T2DM) is a chronic disorder of blood glucose metabolism, which seriously affects human health. In recent 30 years, the prevalence rate of insulin resistance increased rapidly in China, from insulin resistance mainly accompanied by progressive insulin secretion deficiency to insulin progressive secretion insufficiency with different degrees of insulin resistance. Macrovascular complications are the main cause of disability and death. Insulin resistance (IR) refers to the hyperinsulinemia caused by the decrease of glucose uptake and utilization efficiency and the compensatory secretion of insulin. It is generally believed that insulin resistance is the basis of abnormal blood glucose, blood lipids, uric acid and blood pressure, and is an important link in the pathogenesis of metabolic syndrome. Plasma fibrinogen is the central protein of the body's coagulation system and the highest concentration of coagulation factor in the blood circulation. It plays an important role in maintaining the dynamic balance between the fibrinolytic system and the coagulation system in the body. Directly involved in the occurrence and development of atherosclerosis. Studies have shown that insulin resistance may be associated with FIB in obese, polycystic ovary syndrome (PCOS),) gestational diabetes mellitus and elderly type 2 DM patients. The aim of this study was to investigate the relationship between plasma fibrinogen and insulin resistance in patients with type 2 DM. Methods: after excluding non-type 2 diabetic patients and other factors affecting the level of FIB, 1006 patients with type 2 diabetes mellitus were admitted from July 2015 to July 2016 in the Endocrinology Department of our hospital. The age, course and sex of the selected patients were recorded, and fasting venous blood samples were collected within 24 hours after admission to our laboratory for fasting blood glucose (FPG), fasting insulin (Fins), fasting C-peptide (C-P), fasting plasma glucose (FPG), fasting insulin (Fins), fasting C-peptide (C-P). Glycosylated hemoglobin (Hb A1c), triglyceride (TG), plasma cholesterol, (Chol), high density lipoprotein (HDL-C), low density lipoprotein (LDL-C), uric acid (UA), Plasma fibrinogen (FIB) and other related biochemical indexes were measured and HOMA-IR,BMI index was calculated. According to the FIB level of all patients, the quartile method was used to divide into four groups. SPSS20.0 (Ver20.0,IBM,USA) software is used for data analysis. Results: in this study group, 60.3 male patients with type 2 diabetes mellitus were aged 14-90 years with an average age of 55.7 卤12.7 years. The course of disease was distributed between 0-37 years and the mean course of disease was 7.7 卤7.0 years. BMI was distributed in 14.5-40.0 kg/m2, the average BMI25.3 卤3.3 kg/m2,28.9% was not treated, 39.7% received oral hypoglycemic drugs alone, and 14.1% received insulin alone. 17.3% were treated with insulin oral hypoglycemic drugs. Univariate ANOVA analysis showed that the age, course of disease, the level of FIB in women was higher than that in men, and the overall difference between groups was statistically significant (P0.05). Taking FIB as dependent variable, age, course of disease, sex, HOMA-IR,C-P,Hb A _ 1C ~ (+) T _ (TMI) Choll (HDL-C) LDL-CU UA as independent variables, linear stepwise regression analysis was carried out. The results showed that age, course of disease, sex, C-P, and so on. The regression coefficient of Hb A1cU LDL-CU UA was 0.0110.008, and the regression coefficient was 0.0110.0008, respectively. Conclusion: the fasting C-peptide level and the degree of insulin resistance in type 2 diabetes mellitus patients may be the risk factors for the increase of plasma fibrinogen level.
【学位授予单位】:大连医科大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R587.1
【参考文献】
相关期刊论文 前10条
1 贤惠敏;王丽宏;郭译远;车慧;;糖尿病高游离脂肪酸血症与血管内皮细胞功能障碍[J];中华糖尿病杂志;2016年08期
2 黄tD;郑刚;;视黄醇结合蛋白4与心血管疾病关系的研究进展[J];中国心血管杂志;2016年03期
3 周平;罗云;邢娜;卢珊;孙桂波;孙晓波;;肿瘤坏死因子α介导动脉粥样硬化发生机制的研究进展[J];世界中医药;2015年08期
4 晏丕军;张志红;徐勇;朱建华;欧阳芳;万沁;何建华;李佳;马红艳;;2型糖尿病患者血尿酸与血浆致动脉粥样硬化指数的相关性研究[J];中华老年心脑血管病杂志;2015年06期
5 李芳芳;张黎军;田海军;曹俊娜;童晓玲;徐冬;隗玮;许丹;;胰岛素抵抗大鼠血清淀粉样蛋白A、视黄醛结合蛋白4、肝脏抵抗素样分子α的表达及吡格列酮的干预作用[J];中华糖尿病杂志;2015年03期
6 张广平;;影响血管平滑肌细胞迁移的因素[J];临床医药文献电子杂志;2014年14期
7 李昌龙;王志坚;周玉杰;马茜;吉庆伟;赵迎新;;血管外膜脂肪组织源性脂联素通过磷脂酰肌醇-3-激酶/蛋白激酶B信号通路促进血管内膜损伤后内皮细胞增生的研究[J];中国医药;2014年12期
8 韦钰蔓;;非酒精性脂肪性肝病与胰岛素抵抗关系研究[J];内科;2014年05期
9 彭岩;王旭开;;胰岛素对血管平滑肌α肌动蛋白基因变异的影响机制[J];心血管病学进展;2014年03期
10 史珂;韩常宝;王海玲;王禹;;非糖尿病冠心病患者纤溶系统与胰岛素抵抗的相关性分析[J];中国临床医生;2014年04期
,本文编号:2425045
本文链接:https://www.wllwen.com/yixuelunwen/nfm/2425045.html